ArticleESMO gastrointestinal oncology2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.
Y J Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.